Objectives

After participating in this educational activity, attendees should be able to:

1|Summarize HCV+ donor kidney rationale and historical context
2|Summarize recent evidence and outcomes after transplantation
3|Describe monitoring and DAA treatment strategies
4|Discuss drug interactions and immunosuppression

 

Presenter(s): 
Brittney Brzoska, PharmD
PGY2 Ambulatory Care Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Brittney Brzoska, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
09/29/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.